Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase

NCT00025402 is registered in ClinicalTrials.gov with III. Medizinische Klinik Mannheim as lead sponsor.

NCT NCT00025402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Multicenter Treatment Optimization Study In Chronic Myeloid Leukemia (CML) Interferon-a Vs. Allogeneic Stem Cell Transplantation Vs. High-Dose Chemotherapy Followed By Autografting And Interferon-a Maintainance In Early Chronic Phase
Lead sponsor
III. Medizinische Klinik Mannheim
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 1997
Completion date
Not reported
Enrollment
1,000 (estimated)
Sites
188

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia